1.A study on the factors related with hypertriglyceridemia in a humandock center.
Seog Jung JANG ; Yeon Soo LEE ; Hong Soo LEE ; Mi Kyung OH ; Hye Ree LEE ; Bang Bu YOUN ; Byung Yeon YU
Journal of the Korean Academy of Family Medicine 1991;12(9):56-63
No abstract available.
Hypertriglyceridemia*
2.Pharmacological treatment of hypertriglyceridemia.
Journal of the Korean Academy of Family Medicine 2000;21(10):1331-1339
No Abstract Available.
Hypertriglyceridemia*
3.Case Report: Severe hypertriglyceridemia in a nondiabetic treated with low dose insulin infusion
Chin Voon Tong ; Shanty Velaiutham ; Nor Azizah Aziz ; Shueh Lin Lim ; Chong Hui Khaw
The Medical Journal of Malaysia 2015;70(4):249-250
We report a case of a 54-year-old man with severe HTG
which did not respond to conventional anti lipid therapies.
He was treated with intravenous insulin and concurrent
dextrose infusions which led to a dramatic reduction in
serum triglyceride levels.
Hypertriglyceridemia
6.Eruptive Xanthoma with Acute Pancreatitis in a Patient with Hypertriglyceridemia and Diabetes.
Tomoko INOUE-NISHIMOTO ; Takaaki HANAFUSA ; Ayaki HIROHATA ; Eriko KIYOHARA-MABUCHI ; Naho MIZOGUCHI ; Kohei MATSUMOTO ; Sachiko SAKAMOTO ; Masako ZENIBAYASHI ; Satoshi MIYATA ; Ryuta IKEGAMI
Annals of Dermatology 2016;28(1):136-137
No abstract available.
Humans
;
Hypertriglyceridemia*
;
Pancreatitis*
;
Xanthomatosis*
8.Severe hypertriglyceridemia presenting as superior sagittal sinus thrombosis
Debmalya Sanyal ; Soumyabrata Roy Chaudhuri ; Anirban Majumder
Journal of the ASEAN Federation of Endocrine Societies 2014;29(2):190-192
We report a case of a 38-year-old Indian male who presented with severe throbbing headache spreading diffusely from occipital to nuchal regions. He was detected to have superior cerebral (sagittal) venous sinus thrombosis (CVST) with severe hypertriglyceridemia without any coagulation abnormalities or autoimmune disease. Our case highlights the need for clinicians to consider CVST among patients with uncontrolled hypertriglyceridemia. New prognostic measures may become necessary having an implication on the risk of recurrence and duration of anticoagulant therapy in CVST.
Hypertriglyceridemia
;
Venous Thrombosis
;
Headache
10.Clinical Effect of Procetofene(Lipanthyl(R)) on the Serum Lipids in the Hyperlipidemic Patients.
Yun Shik CHOI ; Jeong Sik PARK ; Jeongdon SEO ; Young Woo LEE
Korean Circulation Journal 1981;11(1):113-119
We observed the levels of serum cholesterol, triglyceride and HDL-cholesterol in 28-hyperlipidemic patients after treatment with procetofene(Lipanthyl(R)), a new hypolipidemic agent. The results were as follows. 1. The hyperlipidemic patients were 7 cases of pure hypercholesterolemia, 12 cases of mixed hyperlipidemia and 9 cases of pure hypertriglyceridemia. 2. All the patients were treated with daily dose of 200 to 400mg, usually 300mg, and duration of more than 12 weeks. 3. The serum cholesterol decreased significantly at the rate of 29% in pure hypercholes terolemia and 29% in mixed hyperlipidemia after treatment for 12 weeks. 4. The serum triglyceride decreased significantly at the rate of 58% in mixed hyperlipidemia and 42% in pure hypertriglyceridemia after treatment for 12 weeks. 5. The serum HDL-cholesterol increased at the rate of 10% in pure hypercholesterolemia, 14% in mixed hyperlipidemia and 26% in pure hypertriglyceridemia after treatment for 12 weeks, but the increase rate was statistically significant only in pure hypertriglyceridemia. 6. Transient epigastric discomfort was complained by 2 patients, but subsided spontaneously with continuous treatment. 7. In view of these results, procetofene appears to be an effective and well tolerated agent for the treatment of all the types of hyperlipidemia.
Cholesterol
;
Fenofibrate
;
Humans
;
Hypercholesterolemia
;
Hyperlipidemias
;
Hypertriglyceridemia
;
Triglycerides
Result Analysis
Print
Save
E-mail